MedTrace Logo

Effects of Sensory-Motor Integration Training in Patients with Idiopathic Parkinson's Disease

NCT06390163 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-12-27

No results posted yet for this study

Summary

The goal of this single blind randomized controlled trial is to investigate the effect of sensory-motor integration training on cognitive functions, balance and gait in patients with Parkinson Disease?

The main questions it aims to answer are:

* Does sensory-motor integration training have an effect on balance in patients with Parkinson Disease?
* Does sensory-motor integration training have an effect on cognitive functions in patients with Parkinson Disease?
* Does sensory-motor integration training have an effect on gait in patients with Parkinson Disease? Patients in the control group will be asked to continue their routine lives and return for evaluation after 8 weeks. Individuals in the control group will be followed without any additional treatment or advice. Patients in the study group will receivesensory-motor integration training for 60 minutes, 3 days a week for 8 weeks, in addition to their routine lives. No additional recommendations will be given to individuals in either group.

Conditions

  • Idiopathic Parkinson Disease

Interventions

OTHER

Sensory-Motor Integration Training

An exercise chain consisting of motor tasks, sensory stimuli and cognitive tasks will be created. Each session will include at least 3 motor tasks, 3 sensory stimuli and 3 cognitive tasks selected according to the patient's condition.

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Principal Investigators

  • Ayla Fil Balkan, Assoc.Prof · Hacettepe University

  • Süleyman Korkusuz, PhD · Atılım University

  • Ayşenur Özcan, MSc · Çankırı Karatekin University

  • Gül Yalçın Çakmaklı, Assoc.Prof. · Hacettepe University

  • Öznur Yiğit, Assisst.Prof · Hacettepe University

  • Bülent Elibol, Prof.Dr. · Hacettepe University

  • Büşra Seçkinoğulları Korkusuz, MSc · Hacettepe University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-05
Primary Completion
2024-10-20
Completion
2024-10-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06390163 on ClinicalTrials.gov